Startup profile · funding coverage
Labster funding, valuation and investors
Virtual laboratory simulations for STEM higher-education and corporate training.
Keep track of Labster
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$60M · February 2021
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$60M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Copenhagen, Denmark
Overview
Labster provides virtual laboratory simulations where STEM students run experiments in immersive 3D environments when physical lab access is limited or costly. The platform serves higher-education institutions and corporate training programs with 300+ simulations across biology, chemistry, physics, and engineering. Andreessen Horowitz led a $60M Series C in February 2021 with GGV Capital, Balderton Capital, and Owl Ventures participating.
Why Labster is interesting
Labster democratizes lab access via 3D simulations — a16z led a $60M Series C in 2021 as COVID accelerated digital lab adoption in universities worldwide.
Product & use cases
Labster's 3D virtual labs let students conduct experiments with real scientific methodology — pipetting, microscopy, PCR, and more — in browser-based simulations with assessment and LMS integration.
- University STEM lab courses when physical labs are full or unavailable
- Pre-lab preparation before hands-on sessions
- Corporate biotech and pharma training simulations
- Remote and online degree program lab requirements
Key facts
- Series C (Feb 2021): $60M led by a16z — PR Newswire
- 300+ virtual lab simulations
- Copenhagen-founded; global university customers
Funding history (newest first)
Series C
2021-02 $60MSource: Read source · prnewswire.com
Investors in our directory
Funds linked from Labster's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: 300+ simulation catalog with pedagogical design and LMS integrations — depth competitors struggle to match.
Virtual labs supplement rather than replace physical labs. Labster benefited from COVID-driven adoption but must prove retention post-pandemic. International expansion (US, Europe) diversifies from Danish origins.
-
PraxiLabs direct
Virtual lab simulations for MENA markets.
-
Visible Body adjacent
Anatomy simulations; narrower scope.
-
Physical university labs incumbent
Gold standard but capacity-limited and expensive.
Notable stories
- Labster's $60M Series C in February 2021 came as universities worldwide sought digital lab alternatives during COVID-19 campus closures.
- Founded in Copenhagen in 2011, Labster expanded to US universities before a16z led the growth round.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Labster's financing or category context.
FAQs about Labster
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.